Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma
Chi Hang Wong(Chinese University of Hong Kong), Anthony T.�C. Chan(Chinese University of Hong Kong)
Cited by 34
Related Papers
STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells <i>in vitro</i>
|International Journal of Cancer|2009|70
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
|Investigational New Drugs|2009|44